LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.031623
 51.33 27.76 3629 5117 0.7092 0.9107
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 51.33 27.76 1470 5117 0.2873 0.6946
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 51.33 27.76 4415 5117 0.8628 0.9612
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 53.04 27.76 3849 5365 0.7173 0.9144
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 53.04 27.76 3867 5365 0.7207 0.9156
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 53.04 27.76 1610 5365 0.3001 0.7068
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 53.04 27.76 4647 5365 0.8661 0.9625
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 54.74 27.76 4091 5606 0.7297 0.9194
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 54.74 27.76 4111 5606 0.7333 0.9206
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 54.74 27.76 1785 5606 0.3184 0.7224
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 54.74 27.76 4961 5606 0.8849 0.9683
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 56.45 27.76 4329 5745 0.7535 0.9278
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 56.45 27.76 4354 5745 0.7578 0.9292
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 56.45 27.76 1861 5745 0.3239 0.7274
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 56.45 27.76 5219 5745 0.9084 0.9752
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 58.15 27.76 4560 5906 0.7720 0.9342
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 58.15 27.76 4581 5906 0.7756 0.9353
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 58.15 27.76 1940 5906 0.3284 0.7318
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 58.15 27.76 5503 5906 0.9317 0.9818
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 59.85 27.76 4804 6062 0.7924 0.9410
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 59.85 27.76 4828 6062 0.7964 0.9422
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 59.85 27.76 2069 6062 0.3413 0.7416
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 59.85 27.76 5887 6062 0.9710 0.9925
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 61.56 27.76 5074 6217 0.8161 0.9486
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 61.56 27.76 5099 6217 0.8201 0.9499
MN20160318_Q01
I06